Innovotech Expands Fractional CFO Agreement and Occupies New Office and Lab Space

(TheNewswire)

Edmonton, Alberta, October 6, 2025 – TheNewswire - Innovotech Inc. (TSX-V: IOT)(“Innovotech” or the “Company”) has renewed a contract withBernard Grobbelaar, expanding his commitments to the company asfractional CFO.  The renewal is recognized with 150,000 incentivestock options, vesting immediately, priced at $0.20 and expiring in 5years, granted under the Company’s security incentive plan.  Mr.Grobbelaar is a Chartered Professional Accountant and providesservices through his professional services firm, OikonomosProfessional Corporation.

Innovotech has signed a new lease agreement moving headoffices to Suite C203, 2011 94 St NW, Edmonton, Alberta, T6N 1H1, aswell as gaining additional laboratory spaces within the same building. Concurrently, the Company has retired its laboratory located in anadjacent building.

“This move brings the Company one step closer toconsolidating our operations and makes our antimicrobial contractresearch team more efficient, reducing costs in managing separatespaces,” said Craig Milne, CEO of Innovotech Inc. The lease is forthree years, with a rolling three-month cancellation without penalty,to enable Innovotech to exit if a new space arises that will permitlong term growth.

About Innovotech:

Innovotech Inc. is a diversified Canadian technologycompany with business operations in a growing portfolio of specializedlaboratory services, biotechnology businesses, and proprietaryintellectual property. Innovotech Inc. manages several subsidiarycompanies.  Innovotech Labs Corporation is a contract researchorganization that owns and provides proprietary devices forantimicrobial testing in multiple applications and commercializesantimicrobial silver solutions. Learn more at www.innovotech.ca . Keystone Labs Inc. is a DEL-accredited lab serving theCanadian pharmaceutical industry and industrial markets. Learn more at www.keystonelabs.ca. InnovotechInc. owns a 60% stake in NouLifeSciences Inc., a company holdingintellectual property related to antioxidant molecules with potentialapplications in cosmetics and various medical conditions includingneuropathies.

Craig Milne, CEO Innovotech Inc.

+1-604-239-1819        craig.milne@innovotech.ca

This document may containforward-looking statements that are predictive in nature and subjectto risks and uncertainties that cannot be predicted or quantified;consequently, actual results may differ materially from past resultsand those expressed or implied by any forward-looking statements.Factors that could cause or contribute to such risks or uncertaintiesinclude, but are not limited to: the regulatory environment includingthe difficulty of predicting regulatory outcomes; changes in the valueof the Canadian dollar; the Company’s reliance on a small number ofcustomers including government organizations; fluctuations inoperating results; government policies or actions; progress and costof clinical trials; reliance on key strategic relationships; uncertaintyrelated to intellectual property protection and potential costsassociated with its defense; the Company’s exposure to lawsuits andother matters beyond the control of management. Should known orunknown risks or uncertainties materialize, or should management’sassumptions prove inaccurate, actual results could vary materiallyfrom those anticipated. The Company undertakes no obligation topublicly make or update any forward- looking statements, except asrequired by applicable law.

Neither the TSX Venture Exchange nor its RegulationServices Provider (as that term is defined in the policies of the TSXVenture Exchange) accepts responsibility for the adequacy or accuracyof this release.

###

Copyright (c) 2025 TheNewswire - All rights reserved.